TIAPRIDAL

Medicinal product

(Invented) name

TIAPRIDAL

Active substance (s)

Tiapridas

Strength

100 mg/2 ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05AL03, Tiapride

Marketing authorisation holder

UAB Rx pharma, Lietuva

Date of authorisation

2025-09-12

Date of renewal

Documents

2864_TIAPRIDAL_inj_PZ_2025-09-12.docx

2864_TIAPRIDAL_inj_PL_2025-09-12.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

vienoje ampulėje yra	2 ml
Tiapridas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118642	104746	1104746	ampulė	2 ml N12		Receptinis	LT/L/25/2864/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-09-12	Registruotas